BioPharmaceuticals

Transforming treatment for billions of people living with chronic diseases


Through our work in BioPharmaceuticals, we want to transform healthcare, change the lives of billions of people for the better and address some of the biggest healthcare challenges facing humankind. There remains a huge unmet need in treating people with chronic diseases. Our ambition is to stop the progress of these often degenerative, debilitating, and life-threatening  conditions, achieve remission, and one day cure them.



Introduction

BioPharmaceuticals is responsible for our key therapy areas of Cardiovascular, Renal & Metabolism and Respiratory & Immunology.

Our BioPharmaceuticals R&D and Business Unit are unified in our approach to deliver life-changing medicines for people living with the most common chronic diseases.

We will achieve our ambition of transforming healthcare through our talented teams and partners using scientific, medical and commercial innovation.




BioPharmaceuticals Therapy Areas



BioPharmaceuticals R&D

Our science is changing the trajectory of care across chronic diseases.



Transforming our science

In our aspiration to create the greatest and swiftest impact on disease, we are investing in four areas – enhancing our understanding of disease biology, creating the next generation of therapeutics, better predicting clinical success, and pioneering new approaches to engagement in the clinic and beyond.



What science can do

To unlock the power of what science can do, we are always searching for new knowledge and the next breakthrough. Our culture is a unique blend of inspiring people with curious minds, harnessing data and technology, working seamlessly and inclusively, and always learning from patients.


BioPharmaceuticals Business Unit

Our commercial teams are transforming how we bring products to market; engage with patients, healthcare providers and health systems; and deliver healthcare solutions that support them.



Transforming patient experiences

We are transforming patient experiences by leveraging data analytics, omnichannel approaches, and go to market models that together help inform commercial strategies, improve patient and healthcare professional experiences, and match the evolution of local healthcare ecosystems and channel preferences.


Unlocking the potential of our medicines

The delivery of highly valued market access solutions unlock the potential of our life-changing medicines for patients. We are also integrating science with real-world practice to generate and communicate compelling medical evidence to evolve treatment landscapes and improve care for patients.


Our people

We are enabling the best people to help shape the future of healthcare.

We continue to create a business and culture that attracts and retains the best, most talented and dedicated people, giving them the resources and support to push the boundaries and go beyond the ordinary to help improve billions of lives.

The future of healthcare


Collaborating for success

We know that however innovative our science is, however effective our medicines and delivery are, to achieve all we want to achieve we cannot do it alone. From drug discovery collaborations to commercial partnerships, we aim to create mutually beneficial partnerships founded on trust and transparency.